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Abstract
Background: Conducted pilot study concerning mean platelet volume (MPV) parameter among pa-
tients suffering from congestive heart failure and periodontal disease.
Methods: Examination of dynamic changes of platelet and periodontal markers in group of 50 patients 
before and an average of 6 months subsequent to professional periodontal treatment.
Results: Both platelet and periodontal parameters decreased after periodontal treatment, what is more, 
the decrease of MPV value due to periodontal disease/mm improvement was shown to be statistically 
significant (p = 0.05).
Conclusions: Improvement of periodontal status may influence decrease of MPV value and increase 
of congestive heart failure treatment efficacy and effect patient comfort. It is a new, not frequently used 
pattern of chronic disease treatment optimalization. (Cardiol J 2019; 26, 3: 253–259)
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Introduction
Numerous papers have documented prog-
nostic value of mean platelet volume (MPV) in 
cardiovascular pathology [1–7], including pub-
lished research on correlation between MPV and 
periodontal disease (PDe) in coronary patients [8]. 
A thorough search on correlation between MPV 
and exacerbated heart failure revealed only 2 pub-
lications in this area [9, 10]. MPV has not yet been 
studied in patients with congestive heart failure 
(CHF), including those with coexistent PDe.
The aim of this study was to assess the dynamics 
of changes of MPV in CHF patients with diagnosis of 
PDe. The authors made an attempt to design a clinical 
pilot study that will verify the following hypotheses: 
(A) Is MPV an appropriate marker of periodon-
tal parameters change the dynamics? Analyzed 
BEFORE periodontal intervention; (B)  Is MPV an 
appropriate marker of periodontal parameters change 
the dynamics? Whether a clinical decrease of some 
periodontal parameters (CAL/mm, PI, and PD/mm) 
may result in MPV? Analyzed AFTER periodontal 
intervention.
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There is a correlation between the decrease 
of inflammatory process presented by plasma 
concentration of the following parameters: tumor 
necrosis factor-alpha (TNF-a), N-terminal pro-B-
-type natriuretic peptide (NT-proBNP), C-reactive 
protein (CRP) and improvement of CHF patient 
status, including better prognosis [11–17]. Nu-
merous researchers have shown that elimination 
of inflammation in PDe results in a significant re-
duction of chronic inflammatory process and may 
lead to additional benefits including improvement 
of vascular endothelium [18–22].
Methods
A pilot group of 50 patients aged 36–92 years 
including 15 women and 35 men (average age 
64 years), admitted to the Department of Cardio-
logy of the Medical University of Warsaw with a di-
agnosis of CHF. Those patients were also diagnosed 
with PDe that required periodontal treatment.
This pilot study was conducted in accordance 
with 1964 Declaration of Helsinki and was approved 
by the Ethics Committee of the Medical University 
of Warsaw (KB/54/A/2013). All patients have read 
and signed informed consent forms.
After obtaining their consent, all patients 
enrolled in the study underwent the following 
diagnostic assessment:
 — Biochemical blood tests on admission day and 
on average 6 months after periodontal treat-
ment: blood count, iodine and potassium con-
centration, lipid profile, CRP and TNF-a leve ls, 
NT-proBNP and fibrinogen concentration.
 — Examination of oral hygiene: approximal 
plaque index (API) inspected on approximal 
spaces of the first and third quadrants from 
the oral aspect and of the second and fourth 
quadrant from the buccal aspect and bleeding 
on probing (BOP) probed on 4 surfaces of each 
tooth (mesial, distal, platal/lingual, buccal) 
during initial standard periodontal therapeutic 
assessment (scaling, root-planing, sanitation 
of oral cavity as well as treatment of oral 
mucosa pathologies). Number and status of 
teeth, number and status of impacted teeth, 
gangrenous roots, currently used prosthetic 
restorations, as well as surgical and prosthetic 
treatment indications were assessed [23].
 — Periodontal examination of clinical attach-
ment loss (CAL/mm) and probing depth (PD/ 
/mm) in oral cavity with the use of periodon-
tal probe WHO 621 in 6 measurement points 
around each tooth (mesial buccal, distal buc-
cal, middle of buccal surface, mesial palatal/ 
/lingual, distal palatal/lingual, middle of palatal/ 
/lingual surface) and dental orthopantomogram 
radiograph (OPG) in CHF patients following 
conventional periodontal therapy assessment: 
removal of bacterial biofilm from tooth surface 
(scaling) and smoothing (root-planing) to pre-
vent re-accumulation of bacteria, sanitation 
of oral cavity as well as periodontal reassess-
ment on average 6 months (3–9 months) after 
treatment.
Study patients were treated in accordance 
with current CHF treatment guidelines, without 
need of modifications of pharmacological therapy, 
and their clinical status was stable throughout the 
study. Based upon results of initial examination, 
pilot specialist periodontal treatment was com-
menced in patients with coexistent CHF and PDe 
in a reference clinical center. 
This paper presents statistical analysis of 
a relationship between dynamic MPV changes in 
relation to PDe and oral hygiene status.
Blood samples were collected from all 50 
study patients on admission day (examination-1), 
and then 3–9 months (on average 6 months) after 
periodontal treatment was completed (examina-
tion-2). Blood samples were centrifuged and serum 
was tested for blood count including diagnostic 
parameters of platelet count and volume, which 
were the subject of the study and were further 
analyzed. A standard blood work-up kit (R&D 
Systems, Inc., Minneapolis, USA) was used in 
accordance with manufacturer instructions in the 
Central Laboratory Department of Hematology, 
Oncology and Internal Diseases of the Medical 
University of Warsaw.
The status of CHF was examined before and 
after periodontal therapy by two experienced 
cardiologists blinded to the periodontal therapy 
outcomes and indices.
The periodontal study was conducted at the 
Department of Oral Medicine and Periodontal Dis-
ease of the Medical University of Warsaw, with the 
use of periodontal probe WHO 621. During the ex-
amination antibiotics were administered prophylac-
tically. All patients received Augmentin® (amoxicil-
linum, acidum clavulanicum) 1.0 g (1 d/every 12 h), 
and for those with penicillin intolerance Dalacin C® 
(clindamycinum) 0.3 g (1 d/every 8 h) was pre-
scribed. For periodontal examination, patients 
received single, prophylactic dose (Augmentin® 
— 2 g; Dalacin C® — 0.6 g) according to guidelines 
concerning examination of such patients issued by 
the Polish Society of Periodontology. API/% and 
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BOP/% were assessed, scaling, root-planing and 
orthopantomogram radiograph were performed. 
Detailed instructions for daily oral hygiene were 
provided. The above described activities were termed 
as periodontal intervention.
Following periodontal assessment, also with 
antibiotic administration, examination of clinical at-
tachment loss (CAL/mm) as well as probing depth 
(PD/mm — probing depth), degree of furcation in-
volvement, and 3-stage Hall’s tooth mobility scale, 
where stage 1 represents lingual or buccal/palatal 
mobility, no more than 1 mm; stage 2 — lingual 
or buccal/palatal mobility between 1 and 2 mm; 
stage 3 — vertical and horizontal mobility that 
interrupts proper articulation was performed 
[24, 25]. Each tooth was examined and mean parame-
ters values were calculated for individual patients.
All patients received standard periodontal 
therapy: scaling and root planing with sanitation 
of oral cavity including extraction of gangrenous 
roots under antibiotic prophylaxis regimen. For 
periodontal treatment full antibiotic therapy was 
administered (Augmentin® — 14 doses/7 days; 
Dalacin C® — 15 doses/5 days) according to the 
same guidelines. Recommended oral hygiene at 
home includedbrushing teeth twice a day, in the 
morning and in the evening, as well as antiseptic 
mouth rinsing. Patients were encouraged to stay 
in touch with researchers in case of any doubts re-
garding their oral cavity status and hygiene routine.
Statistical analysis
Obtained  results underwent statistical analy-
sis in order to assess the influence of treatment on 
MPV with reference to selected periodontal param-
eters. Following statistical tests were performed 
to verify stated hypotheses. 
Statistical analysis was performed with Mann-
Whitney test for dependent groups to verify differ-
ences between observations and Wilcoxon test to 
assess differences between selected study groups 
(H.B. Mann, D.R. Whitney [1947] “On a test of 
whether one of two random variables is stochasti-
cally larger than the other”. Annals of Mathematical 
Statistics, 18, 50–60). 
Results
All patients were diagnosed with severe chron-
ic generalized periodontitis (CAL > 5 mm and PD 
> 7 mm) according to American Academy of Peri-
odontology 2000 classification [26].
Pilot study of 50 CHF patients with coexist-
ent PDe on admission day has shown that mean 
API and BOP values were very high, respectively: 
API: 74% in women and 81% in men; BOP: 100% 
in women and 90% in men. Mean PD/mm values 
both for women and men were 5.7 mm. Mean CAL/ 
/mm values were 5.2 mm for women and 5.3 mm for 
men. Among women the average number of teeth 
in the upper arch was 12 and in lower arch — 11. 
In the group of men the average number of teeth 
in maxilla was 11 and in mandible — 10. 
A. Study results show that as far as first hy-
pothesis is concerned, patients before periodontal 
intervention, high values of MPV parameter have 
shown correlation with high values of the following 
parameters: CAL/mm, plaque index (PI) and PD/mm 
obtained during the first assessment (examination-1).
A.I. MPV vs. CAL/mm (examination-1)
Statistical analysis has shown that higher 
MPV value is associated with higher CAL/mm 
value. Presented model did not show statistically 
significant relationship. The numerical relationship 
was positive. The following results were obtained: 
statistical value W: 0.3694; p: 0.5462 (Fig. 1).
A.II. MPV vs. PD/mm (examination-1)
Statistical analysis has shown that PD/mm 
values are subtle. In addition: although there is 
no clear trend in relationship between these pa-
rameters a positive trend is present, the highest 
MPV values are for patients with PD/mm 7 mm 
(the highest) value obtained (Fig. 2).
Figure 1. The values of mean platelet volume (MPV) vs. 
clinical attachment loss (CAL/mm) before periodontal 
intervention (MPV ± SD 0.91; CAL/mm ± SD 0.39); 
SD — standard deviation.
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B. Study results show that as far as second hy-
pothesis is concerned in patients after periodontal 
intervention high values of MPV parameter have 
shown correlation with high values of the following 
parameters: CAL/mm, PI and PD/mm, obtained 
during the second assessment (examination-2).
B.I. MPV vs. CAL/mm (examination-2)
Statistical analysis has shown that there is vir-
tually no relationship between CAL/mm and MPV 
value after periodontal intervention. The presented 
model did not show any statistically significant 
relationship. The following results were obtained: 
statistical value W: 0.03385; p: 0.8548 (Fig. 3).
B.II. MPV vs. PD/mm (examination-2)
Statistical analysis has shown that PD/mm 
values are subtle. In addition: there is a positive 
trend (higher PD/mm is associated with higher 
MPV value), and the highest MPV values are for 
PD/mm 5 mm (the highest) (Fig. 4).
B.III. MPV change vs. CAL/mm change
Assessment whether CAL/mm parameters 
change observed before and after periodontal in-
tervention is associated with MPV. For CAL/mm 
change at 1.5 mm MPV is higher and characterized 
with grater variability. Following results were ob-
tained: statistical value W: 306.5; p: 0.3076 (Fig. 5).
Results show that this difference is not signifi-
cant. It should be noted that for greater CAL/mm 
change MPV distribution towards higher values 
was observed. It is therefore justified that the 
change of CAL value has influenced an increased 
MPV distribution.
B.IV. MPV change vs. PD/mm change
Correlation between PD/mm parameter change 
before and after periodontal intervention and MPV 
was tested. PD/mm value changes are subtle, and 
importantly values 1 and 4 are scarce and will not 
be further analyzed. The following results were ob-
tained: statistical value W: 0.3694; p: 0.5462 (Fig. 6).
Figure 2. The values of mean platelet volume (MPV) vs. 
probing depth (PD/mm) before periodontal intervention 
(MPV ± SD 0.91; PD/mm ± SD 0.60); SD — standard 
deviation.
Figure 3. The values of mean platelet volume (MPV) 
vs. clinical attachment loss (CAL/mm) after periodontal 
intervention (MPV ± SD 0.98; CAL/mm ± SD 0.80); 
SD — standard deviation.
Figure 4. The values of mean platelet volume (MPV) vs. 
probing depth (PD/mm) after periodontal intervention 
(MPV ± SD 0.98; PD/mm ± SD 0.74); SD — standard 
deviation.
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There is positive relationship between PD/mm 
change and MPV change. PD/mm value change af-
ter value 1 and 4 were deleted is shown on the box 
plot. For larger PD/mm value changes increased 
MPV value change occurred. The test has shown 
a statistically significant difference of 5%.
Periodontal assessment was performed after 
PDe treatment (the so called periodontal inter-
vention) was completed. The number of patients 
remained constant during whole study. API values 
decreased to 28% among women and 30% among 
men. BOP also significantly decreased to 36% in 
women group and 41% in men. Both gender groups 
resulted in CAL/mm value 4.0 mm and PD/mm 
3.3 mm. After oral cavity sanitation, the average 
number of remaining teeth in women was 10 for 
maxilla and 9 for mandible, among men 9 and 8, 
respectively.
Discussion
Fifty patients ≤ 92 years (age: 36–92; mean 
age: 64 years) with CHF and PD diagnosis were 
enrolled into this pilot study. It was found that MPV 
measurements on admission day as well as clinical 
periodontal assessment (examination-1) are differ-
ent from results obtained after standard periodontal 
treatment (examination-2). S A statistically signifi-
cant decrease of PD value over a of mean of a 6 month 
observation period (3–9 months) was noted.
In addition to a decrease of BOP and PI values 
in all study patients, mean increase in CAL/mm 
values of 1.5 mm was noted showing advantage 
of restoration over destruction processes within 
alveolar bone of maxilla and mandible. It should 
be noted that no highly specialized Guided Bone 
Regeneration (GBR) and/or Guided Tissue Re-
generation (GTR) procedures were  performed, 
justifying potential likelihood of including this type 
of therapy into CHF treatment standard.
Significant correlation between a decrease of 
clinical PD/mm values and increased MPV value 
change and decrease should be noted. Statistical 
analysis has shown that the decrease in PD/mm 
value which is much easier to obtain by basic dental 
care, has resulted in better effects in study group 
patients than CAL/mm decrease that can be mainly 
obtained only by highly specialized, expensive peri-
odontal procedures.
In this pilot study group during a 6-month 
observation no signs of heart failure exacerbation 
were observed, and pharmacological therapy that 
was in accordance with current CHF treatment 
guidelines, required no modifications of each me-
dicament dose and type (Tables 1 and 2).
Authors of this paper have focused their re-
search on the relationship between PDe and heart 
disease. Current studies and observations as well 
as published results referred patients who were 
hospitalized due to acute coronary syndromes 
[11–15, 27]. Results of this pilot study have shown 
that proper and complex oral hygiene may influ-
ence blood serum levels of CRP, NT-proBNP and 
TNF-a which are all markers of inflammation [18, 
28–32]. Individualized patterns of CHF patient 
Figure 5. The values of D mean platelet volume (DMPV) 
vs. D clinical attachment loss (DCAL/mm) during experiment 
observation (DMPV ± SD 14.58; DCAL/mm ± SD 53.51); 
SD — standard deviation.
Figure 6. The values of D mean platelet volume (DMPV) 
change vs. D probing depth (DPD/mm) during experiment 
observation (DMPV ± SD 14.58; DPD/mm ± SD 7.42); 
SD — standard deviation.
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care, seems obvious and also results in prognosis 
improvement, increased treatment efficacy and 
patient comfort [33–35].
Limitations of the study
The main limitation of the study was the 
small group of patients included. Secondly,  was 
the absence of a control group. However, it is 
very difficult to create such a control group for 
two reasons. One — patients could not be found 
with CHF and a healthy peridontium in among the 
general population. Secondly, it would be ethically 
controversial to treat PDe only in a subgroup of 
patients. Therefore, after taking into considera-
tion the Ethics Committee opinion on this study, 
we have decided to perform it in this form and call 
it a pilot study.
Conclusions
Results of this pilot study should be verified 
in a larger patient cohort. The results of this study 
show that:
 — decreases of PD/mm results in significantly 
better results of MPV (p = 0.05) than reduc-
tion of CAL/mm value;
 — specialist periodontal treatment may result in 
decreased MPV value in patients with coexist-
ent CHF and PDe;
 — examed platelet parameter may have prog-
nostic value in CHF, periodontal treatment of 
CHF and PDe patients might improve their 
long-term prognosis, but it ought to be verified 
in a prospective study;
 — the above conclusions are, to the authors’ best 
knowledge, first published conclusions in this 
area and require verification on a larger patient 
population. 
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